Clincosm LogoSign in Get a demo

dedifferentiated liposarcoma

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dedifferentiated Liposarcoma Patients in China

Not yet recruiting
  • Dedifferentiated Liposarcoma
    • Beijing, China
      Beijing Jishuitan hospital
    Oct 30, 2023

    Dedifferentiated Liposarcoma, Soft Tissue Sarcoma, Sarcoma,Soft Tissue Trial in United States (Etrumadenant, Zimberelimab)

    Recruiting
    • Dedifferentiated Liposarcoma
    • +6 more
    • Basking Ridge, New Jersey
    • +6 more
    May 23, 2023

    Dedifferentiated Liposarcoma Trial in Worldwide (Selinexor, Placebo)

    Completed
    Has Results
    • Dedifferentiated Liposarcoma
    • Los Angeles, California
    • +70 more
    Jan 5, 2023

    Sarcoma, Advanced Sarcoma, High Grade Sarcoma Trial in New York (DCC-3014, Avelumab)

    Active, not recruiting
    • Sarcoma
    • +6 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Oct 26, 2022

    Sarcoma, Dedifferentiated Liposarcoma Trial in New York (Abemaciclib)

    Active, not recruiting
    • Sarcoma
    • Dedifferentiated Liposarcoma
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Aug 17, 2022

    Dedifferentiated Liposarcoma Trial in Beijing, Shanghai (TQB3616 capsule, TQB3616 )

    Not yet recruiting
    • Dedifferentiated Liposarcoma
    • TQB3616 capsule
    • TQB3616 placebo
    • Beijing, Beijing, China
    • +2 more
    Aug 9, 2022

    Dedifferentiated Liposarcoma Trial in Worldwide (RAIN-32, Trabectedin)

    Active, not recruiting
    • Dedifferentiated Liposarcoma
    • Palo Alto, California
    • +70 more
    Aug 4, 2022

    Dedifferentiated Liposarcoma, Recurrent Dedifferentiated Liposarcoma, Recurrent Undifferentiated Pleomorphic Sarcoma Trial in

    Active, not recruiting
    • Dedifferentiated Liposarcoma
    • +5 more
    • Ipilimumab
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 25, 2022

    Dedifferentiated Liposarcoma Trial in Worldwide (Cabazitaxel)

    Completed
    • Dedifferentiated Liposarcoma
    • Antwerpen, Belgium
    • +10 more
    Sep 10, 2021

    Sarcoma, Fibrosarcoma, Leiomyosarcoma Trial in Warsaw (Sequential chemo - 3 courses of AI, Hypofractionated radiotherapy)

    Unknown status
    • Sarcoma
    • +16 more
    • Sequential chemotherapy - 3 courses of AI
    • Hypofractionated radiotherapy
    • Warsaw, Mazovian, Poland
      Maria Sklodowska-Curie Institute - Oncology Center
    Jan 19, 2021

    Dedifferentiated Liposarcoma Trial in Boston (IPI-504)

    Withdrawn
    • Dedifferentiated Liposarcoma
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Apr 13, 2015